港股公告掘金 | 美格智能、埃斯顿、兆威机电及优乐赛共享今日起招股

Major Events - 德视佳 (01846) plans to acquire FYEO Europe B.V., a leading refractive surgery company in the Netherlands, with a significant investment [1] - 美格智能 (03268) is set to launch an IPO from February 27 to March 5, aiming to globally offer 35 million H-shares [1] - 埃斯顿 (02715) will also conduct an IPO from February 27 to March 4, with a global offering of 96.78 million H-shares [1] - 兆威机电 (02692) is expected to list on March 9 after its IPO from February 27 to March 4 [1] - 优乐赛共享 (02649) plans to globally offer 20.336 million H-shares during its IPO from February 27 to March 4 [1] - 蔚来-SW (09866) subsidiary has signed a final agreement for a 2.257 billion RMB investment [1] - 贪玩 (09890) has secured exclusive operation rights for the game "天龙八部2：飞龙战天" and invested in game developer 上海阅龙 [1] - 贝康医疗-B (02170) received a medical device registration certificate from the National Medical Products Administration for its Geri embryo culture solution [1] Operating Performance - 百度集团-SW (09888) reported Q4 revenue of 32.7 billion RMB, a 5% quarter-on-quarter increase, with "萝卜快跑" total order volume growing over 200% year-on-year [2] - 香港交易所 (00388) announced a 2025 full-year profit attributable to shareholders of 17.754 billion HKD, a 36% year-on-year increase [2] - 新鸿基地产 (00016) reported a mid-year profit attributable to shareholders of 10.247 billion HKD, a 36.21% year-on-year growth [2] - 银河娱乐 (00027) posted an annual profit attributable to shareholders of 10.7 billion HKD, a 22% increase year-on-year [2] - 周大福创建 (00659) reported a mid-year profit attributable to shareholders growing 15% year-on-year to 1.3343 billion HKD [2] - 百济神州 (06160) showed strong growth in 2025 with an adjusted net profit of approximately 918 million USD, returning to profitability [2] - 再鼎医药 (09688) reported total revenue of 460.2 million USD in 2025, a 15% year-on-year increase, with significant progress in its global innovation pipeline [2] - 百奥赛图-B (02315) released a 2025 annual performance report showing a net profit of 173 million RMB, a 416.37% year-on-year increase [2] - 康希诺生物 (06185) reported a 2025 annual performance report with a net profit of 27.827 million RMB, returning to profitability [2] - 中电控股 (00002) announced an annual profit attributable to shareholders of 10.468 billion HKD, a 10.85% year-on-year decrease [2] - 正力新能 (03677) expects a net profit increase of up to eight times in 2025, estimated at 680 to 820 million RMB, significantly exceeding market expectations [2] - 至源控股 (00990) issued a profit warning, anticipating a 126% year-on-year increase in net profit to approximately 840 million RMB in 2025 [2]